Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study
- PMID: 23334906
- DOI: 10.1007/s40261-013-0053-5
Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study
Abstract
Background: Augment(®) Bone Graft is a bone graft substitute intended to be used as an alternative to autologous bone graft in the fusion of hindfoot and ankle joints. Augment(®) Bone Graft is a combination device comprised of beta-tricalcium phosphate (β-TCP) and recombinant human platelet-derived growth factor BB homodimer (rhPDGF-BB).
Objective: This human pharmacokinetic study was undertaken to assess the effect of Augment(®) Bone Graft implantation on the serum concentration of platelet-derived growth factors (PDGFs).
Methods: Under the terms of a Research Ethics Board-approved protocol, Augment(®) Bone Graft was implanted in patients (n = 7) undergoing hindfoot and ankle arthrodesis procedures requiring graft material. The control cohort of the study (n = 4) received autologous bone graft. The serum concentrations of PDGF isoforms AA, AB and BB in blood samples, obtained prior to and at ten time points (up to 7 days) after surgery, were measured using enzyme-linked immunosorbent assays (ELISA).
Results: The serum concentration of PDGF-BB did not vary significantly from baseline (median of the combined cohorts 3.89 ng/mL) throughout the course of the study. The serum concentrations of PDGF-AA, PDGF-AB and total PDGF did not deviate from their baseline values (medians of the combined cohorts were 2.87, 14.95 and 20.19 ng/mL for PDGF-AA, PDGF-AB and total PDGF, respectively) except for the last time point in which they were increased (medians for the combined cohorts were 4.71, 20.42 and 30.29 ng/mL for PDGF-AA, PDGF-AB and total PDGF, respectively). There were no differences between the two treatment groups with regard to changes in the serum concentrations of PDGF. None of the samples tested contained anti-PDGF-BB antibodies.
Conclusion: Analysis of the data demonstrated that the serum concentrations of all three PDGF isoforms analysed were unaffected by implantation of Augment(®) Bone Graft.
Similar articles
-
Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft.J Bone Joint Surg Am. 2013 Jul 3;95(13):1184-92. doi: 10.2106/JBJS.K.01422. J Bone Joint Surg Am. 2013. PMID: 23824386 Clinical Trial.
-
Prospective Randomized Controlled Trial of Hindfoot and Ankle Fusions Treated With rhPDGF-BB in Combination With a β-TCP-Collagen Matrix.Foot Ankle Int. 2015 Jul;36(7):739-48. doi: 10.1177/1071100715576370. Epub 2015 Apr 6. Foot Ankle Int. 2015. PMID: 25848134 Clinical Trial.
-
Recombinant Human Platelet-Derived Growth Factor BB in Combination With a Beta-Tricalcium Phosphate (rhPDGF-BB/β-TCP)-Collagen Matrix as an Alternative to Autograft.Foot Ankle Int. 2019 Sep;40(9):1068-1078. doi: 10.1177/1071100719851468. Epub 2019 Jun 7. Foot Ankle Int. 2019. PMID: 31170812 Clinical Trial.
-
Vancouver Experience of Recombinant Human Platelet-Derived Growth Factor.Foot Ankle Clin. 2016 Dec;21(4):771-776. doi: 10.1016/j.fcl.2016.07.009. Foot Ankle Clin. 2016. PMID: 27871410 Review.
-
A Multicenter, Retrospective, Case Series of Patients With Charcot Neuroarthropathy Deformities Undergoing Arthrodesis Utilizing Recombinant Human Platelet-derived Growth Factor With Beta-Tricalcium Phosphate.J Foot Ankle Surg. 2021 Jan-Feb;60(1):74-79. doi: 10.1053/j.jfas.2020.08.030. Epub 2020 Sep 5. J Foot Ankle Surg. 2021. PMID: 33158722 Review.
Cited by
-
Differentiation of Murine Bone Marrow-Derived Smooth Muscle Progenitor Cells Is Regulated by PDGF-BB and Collagen.PLoS One. 2016 Jun 3;11(6):e0156935. doi: 10.1371/journal.pone.0156935. eCollection 2016. PLoS One. 2016. PMID: 27258003 Free PMC article.
-
An Update on the Clinical Efficacy and Safety of Collagen Injectables for Aesthetic and Regenerative Medicine Applications.Polymers (Basel). 2023 Feb 17;15(4):1020. doi: 10.3390/polym15041020. Polymers (Basel). 2023. PMID: 36850304 Free PMC article. Review.
-
Role of xenogenous bovine platelet gel embedded within collagen implant on tendon healing: an in vitro and in vivo study.Exp Biol Med (Maywood). 2015 Feb;240(2):194-210. doi: 10.1177/1535370214554532. Epub 2014 Oct 22. Exp Biol Med (Maywood). 2015. PMID: 25341879 Free PMC article.
-
Decreased serum platelet derived growth factor BB levels in acute and increased in chronic pancreatitis.World J Gastroenterol. 2014 Sep 28;20(36):13127-32. doi: 10.3748/wjg.v20.i36.13127. World J Gastroenterol. 2014. PMID: 25278706 Free PMC article.
-
Tendon tissue engineering and its role on healing of the experimentally induced large tendon defect model in rabbits: a comprehensive in vivo study.PLoS One. 2013 Sep 5;8(9):e73016. doi: 10.1371/journal.pone.0073016. eCollection 2013. PLoS One. 2013. PMID: 24039851 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources